|
US6635676B2
(en)
*
|
1999-04-28 |
2003-10-21 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
US6506803B1
(en)
*
|
1999-04-28 |
2003-01-14 |
Regents Of The University Of Michigan |
Methods of preventing and treating microbial infections
|
|
US7767216B2
(en)
*
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
|
US7655252B2
(en)
*
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
US8232320B2
(en)
*
|
1999-04-28 |
2012-07-31 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
TR200200776T2
(tr)
*
|
1999-09-24 |
2002-06-21 |
Smithkline Beecham Biologicals S.A. |
Burun içi grip virüsü aşısı.
|
|
US6794352B2
(en)
|
2000-06-12 |
2004-09-21 |
Jeffrey S. Svendsen |
Cleaning towel having a color identifying label and sanitizer release polymer composition
|
|
EP2545937A1
(en)
*
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
JP2010209109A
(ja)
*
|
2001-06-25 |
2010-09-24 |
Regents Of The Univ Of Michigan |
抗微生物ナノエマルジョンの組成物および方法
|
|
WO2003020024A2
(en)
*
|
2001-08-28 |
2003-03-13 |
Eden Research Plc |
Treatment and prevention of infections in plants
|
|
US6667290B2
(en)
|
2001-09-19 |
2003-12-23 |
Jeffrey S. Svendsen |
Substrate treated with a binder comprising positive or neutral ions
|
|
US7745686B2
(en)
|
2001-11-02 |
2010-06-29 |
Playtex Products, Inc. |
Catamenial device
|
|
US7799968B2
(en)
*
|
2001-12-21 |
2010-09-21 |
Kimberly-Clark Worldwide, Inc. |
Sponge-like pad comprising paper layers and method of manufacture
|
|
US20030175318A1
(en)
*
|
2002-03-06 |
2003-09-18 |
Schilling Amanda S. |
Application of germination solution improved efficacy of biological decontamination
|
|
DE60215558T2
(de)
*
|
2002-04-17 |
2007-08-02 |
Agribiotec S.R.L. |
Benutzung von pflanzlichem öl als adjuvantien für fungizide, bakterizide, insektizide oder herbizide substanzen
|
|
GB0213097D0
(en)
|
2002-06-07 |
2002-07-17 |
Autoglym |
Improvements in or relating to organic matter
|
|
US7994079B2
(en)
*
|
2002-12-17 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Meltblown scrubbing product
|
|
US20040111817A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Kimberly-Clark Worldwide, Inc. |
Disposable scrubbing product
|
|
BRPI0408099B1
(pt)
|
2003-03-05 |
2014-04-08 |
Byocoat Entpr Inc |
Solução antimicrobiana e processo
|
|
WO2005002337A1
(en)
*
|
2003-04-02 |
2005-01-13 |
Virtual Drug Development, Inc. |
Disinfectant compositions and methods
|
|
US20040204496A1
(en)
*
|
2003-04-11 |
2004-10-14 |
Ammon Daniel M. |
Disinfecting solutions effective against bacterial endospores
|
|
EP1633322A2
(en)
*
|
2003-06-04 |
2006-03-15 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
|
US20050208083A1
(en)
*
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
|
US7348097B2
(en)
*
|
2003-06-17 |
2008-03-25 |
Medtronic, Inc. |
Insulative feed through assembly for electrochemical devices
|
|
EP1648412B1
(en)
*
|
2003-07-07 |
2007-11-14 |
Nares AB |
Microemulsions and its use for preventing airway diseases
|
|
US8211448B2
(en)
*
|
2003-07-07 |
2012-07-03 |
Nares Ab |
Microemulsions and its use for preventing airway diseases
|
|
CA2545117A1
(en)
*
|
2003-11-07 |
2005-05-26 |
Viratox, L.L.C. |
Virucidal activities of a combination of cetylpyridinium chloride and citric acid
|
|
US20090232748A1
(en)
*
|
2003-11-07 |
2009-09-17 |
Viratox, L.L.C. |
Virucidal activities of cetylpyridinium chloride
|
|
US20050100601A1
(en)
*
|
2003-11-07 |
2005-05-12 |
Viratox, L.L.C. |
Virucidal activities of cetylpyridinium chloride
|
|
US20050130536A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Disposable scrubbing product
|
|
US20050129897A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Disposable scrubbing product
|
|
US20050136772A1
(en)
*
|
2003-12-23 |
2005-06-23 |
Kimberly-Clark Worldwide, Inc. |
Composite structures containing tissue webs and other nonwovens
|
|
PL1711058T3
(pl)
*
|
2004-01-23 |
2022-02-07 |
Eden Research Plc |
Sposoby zabijania nicieni obejmujące aplikację składnika terpenowego
|
|
US7707931B2
(en)
|
2004-04-06 |
2010-05-04 |
West Liberty Foods, L.L.C. |
Clean room food processing systems, methods and structures
|
|
PT2338332E
(pt)
*
|
2004-05-20 |
2014-05-15 |
Eden Research Plc |
Partícula oca de glucano ou partícula de parede celular que encapsula um componente de terpeno
|
|
US20050260138A1
(en)
*
|
2004-05-21 |
2005-11-24 |
Virgil Flanigan |
Producton and use of a gaseous vapor disinfectant
|
|
NZ534007A
(en)
|
2004-07-09 |
2007-06-29 |
Horticulture & Food Res Inst |
Fungicidal composition comprising anhydrous milk fat (AMF) and soybean oil for the treatment of Powdery Mildew
|
|
US20060135026A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Kimberly-Clark Worldwide, Inc. |
Composite cleaning products having shape resilient layer
|
|
US20060204469A1
(en)
*
|
2005-03-09 |
2006-09-14 |
Eric Spengler |
Stable mixed emulsions
|
|
EP1871349A1
(en)
*
|
2005-04-11 |
2008-01-02 |
Nanobio Corporation |
Quaternary ammonium halides for treatment of infectious conditions
|
|
US20060292248A1
(en)
*
|
2005-06-20 |
2006-12-28 |
Bio-Germ Protection, Llc |
Biological attack protection kit and method
|
|
US20070015738A1
(en)
*
|
2005-07-15 |
2007-01-18 |
Walker Stephen G |
Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
|
|
WO2008051186A2
(en)
|
2005-08-09 |
2008-05-02 |
Nanobio Corporation |
Nanoemulsion containing compositions having ant i -inflammatory activity
|
|
WO2007030104A1
(en)
*
|
2005-09-03 |
2007-03-15 |
Byocoat Enterprises, Inc. |
Antimicrobial solutions and process related thereto
|
|
WO2007040598A2
(en)
*
|
2005-09-19 |
2007-04-12 |
Combe Incorporated |
Stable emulsion systems with high salt tolerance
|
|
WO2007063267A1
(en)
|
2005-11-30 |
2007-06-07 |
Eden Research Plc |
Terpene-containing compositions and methods of making and using them
|
|
KR101478012B1
(ko)
|
2005-11-30 |
2015-01-02 |
에덴 리서치 피엘씨 |
티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
|
|
TWI458495B
(zh)
*
|
2006-03-23 |
2014-11-01 |
Glaxosmithkline Llc |
牙齒器具清潔劑
|
|
US10138279B2
(en)
|
2006-04-13 |
2018-11-27 |
Regents Of The University Of Michigan |
Compositions and methods for Bacillus anthracis vaccination
|
|
US20080038295A1
(en)
*
|
2006-04-13 |
2008-02-14 |
Regents Of The University Of Michigan |
Compositions and methods for orthopox virus vaccination
|
|
US9839685B2
(en)
*
|
2006-04-13 |
2017-12-12 |
The Regents Of The University Of Michigan |
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
|
|
US8741954B2
(en)
*
|
2007-02-21 |
2014-06-03 |
Viratox, L.L.C. |
Synergistic enhancement of calcium propionate
|
|
CN101032507B
(zh)
*
|
2007-04-06 |
2010-09-29 |
西北农林科技大学 |
一种红霉素纳米乳抗菌药物及其制备方法
|
|
EP2152304B1
(en)
|
2007-05-02 |
2018-08-22 |
The Regents of the University of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
|
EP2280690A2
(en)
*
|
2008-04-18 |
2011-02-09 |
Nanobio Corporation |
Methods for treating herpes virus infections
|
|
EP3023107A1
(en)
|
2008-04-21 |
2016-05-25 |
Nanobio Corporation |
Nanoemulsion influenza vaccine
|
|
WO2009132343A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Nanobio Corporation |
Nanoemulsions for treating onchomycosis
|
|
CA2722445A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Nanobio Corporation |
Nanoemulsions for treating fungal, yeast and mold infections
|
|
CA2725381A1
(en)
*
|
2008-05-23 |
2010-03-25 |
The Regents Of The University Of Michigan |
Nanoemulsion adjuvants
|
|
US9415006B2
(en)
*
|
2008-05-23 |
2016-08-16 |
The Regents Of The University Of Michigan |
Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
|
|
FR2933104B1
(fr)
*
|
2008-06-26 |
2015-10-09 |
Biomerieux Sa |
Milieu de culture comportant un compose inhibiteur ou retardateur de germination de spores
|
|
RU2371328C1
(ru)
*
|
2008-07-01 |
2009-10-27 |
Государственное образовательное учреждение высшего профессионального образования Иркутский государственный университет |
Способ временной обратимой консервации артефактов
|
|
WO2010036945A2
(en)
*
|
2008-09-26 |
2010-04-01 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
|
CN102202672A
(zh)
|
2008-10-10 |
2011-09-28 |
达拉生物科学公司 |
使用穗霉素衍生物治疗或预防疼痛的方法
|
|
US9974844B2
(en)
|
2008-11-17 |
2018-05-22 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
|
WO2010061330A1
(en)
*
|
2008-11-26 |
2010-06-03 |
Viroblock S.A. |
Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules
|
|
EP2391342A2
(en)
*
|
2009-01-28 |
2011-12-07 |
Nanobio Corporation |
Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
|
|
WO2010132833A1
(en)
|
2009-05-14 |
2010-11-18 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
|
NZ597182A
(en)
|
2009-05-22 |
2014-07-25 |
Genocea Biosciences Inc |
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
ES2566646T3
(es)
*
|
2009-06-16 |
2016-04-14 |
The Regents Of The University Of Michigan |
Vacunas en nanoemulsión
|
|
US20110135702A1
(en)
*
|
2009-12-09 |
2011-06-09 |
Hoffman Douglas R |
Sporicidal composition for clostridium difficile spores
|
|
US20110200683A1
(en)
*
|
2010-02-16 |
2011-08-18 |
Piper Medical, Inc |
Hydrogen peroxide solution producing first aid substance, packaging, and treatment
|
|
US20110229516A1
(en)
*
|
2010-03-18 |
2011-09-22 |
The Clorox Company |
Adjuvant phase inversion concentrated nanoemulsion compositions
|
|
US20110229512A1
(en)
*
|
2010-03-19 |
2011-09-22 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
|
MX349265B
(es)
|
2010-05-20 |
2017-07-20 |
Ecolab Usa Inc |
Composiciones antimicrobianas liquidas de baja formacion de espuma, modificadas reologicamente, y sus metodos de uso.
|
|
JP2014520805A
(ja)
|
2011-07-06 |
2014-08-25 |
ナノバイオ コーポレーション |
ヒト呼吸器合胞体ウイルスワクチン
|
|
CA2845872C
(en)
|
2011-08-22 |
2023-03-28 |
Nanobio Corporation |
Herpes simplex virus nanoemulsion vaccine
|
|
CN104093421A
(zh)
|
2011-09-09 |
2014-10-08 |
纳诺碧欧公司 |
纳米乳液呼吸道合胞病毒(rsv)亚单位疫苗
|
|
WO2013078299A1
(en)
|
2011-11-23 |
2013-05-30 |
Genocea Biosciences, Inc. |
Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
|
CN102526139A
(zh)
*
|
2012-02-23 |
2012-07-04 |
华子昂 |
一种人工阴道液及其制备方法
|
|
FR2997304B1
(fr)
*
|
2012-10-26 |
2017-07-07 |
Isp Investments Inc |
Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
|
|
GB201220940D0
(en)
|
2012-11-21 |
2013-01-02 |
Eden Research Plc |
Method P
|
|
CN103830726A
(zh)
*
|
2012-11-23 |
2014-06-04 |
魏维 |
抗微生物有机纳米组合物及其制备方法
|
|
KR20140141857A
(ko)
*
|
2013-05-31 |
2014-12-11 |
한국생명공학연구원 |
패실로마이세스 속 균주를 이용한 생물 농약 제조방법
|
|
EP3204039B1
(en)
|
2014-10-10 |
2022-06-08 |
The Regents Of The University Of Michigan |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
|
WO2016179112A1
(en)
|
2015-05-01 |
2016-11-10 |
Precision Biosciences, Inc. |
Precise deletion of chromoscomal sequences in vivo and treatment of nucleotide repeat expansion disorders using engineered nucleases
|
|
WO2017007835A1
(en)
|
2015-07-07 |
2017-01-12 |
Nanobio Corporation |
Methods and compositions for nanoemulsion vaccine formulations
|
|
WO2017044649A1
(en)
|
2015-09-08 |
2017-03-16 |
Precision Biosciences, Inc. |
Treatment of retinitis pigmentosa using engineered meganucleases
|
|
EP3756682B8
(en)
|
2015-10-05 |
2022-04-27 |
Precision Biosciences, Inc. |
Genetically-modified cells comprising a modified human t cell receptor alpha constant region gene
|
|
CA3001008A1
(en)
|
2015-10-05 |
2017-04-13 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
|
|
WO2017112859A1
(en)
|
2015-12-23 |
2017-06-29 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene
|
|
GB2570382B
(en)
|
2016-04-27 |
2020-07-29 |
Univ Puerto Rico |
1,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases
|
|
CA3022801A1
(en)
|
2016-05-03 |
2017-11-09 |
Precision Biosciences, Inc. |
Engineered nucleases useful for treatment of hemophilia a
|
|
US12076397B2
(en)
|
2016-05-10 |
2024-09-03 |
The Regents Of The University Of Michigan |
Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
|
|
WO2017201390A1
(en)
|
2016-05-19 |
2017-11-23 |
The Regents Of The University Of Michigan |
Novel adjuvant compositions
|
|
JP6897031B2
(ja)
*
|
2016-09-01 |
2021-06-30 |
住友ベークライト株式会社 |
防カビ剤、防カビ樹脂フィルム、防カビ積層フィルム及び防カビ包装体
|
|
JP2019537555A
(ja)
|
2016-09-28 |
2019-12-26 |
ジェノセア バイオサイエンシーズ， インコーポレイテッド |
ヘルペスを処置するための方法および組成物
|
|
EP3523326B1
(en)
|
2016-10-04 |
2020-06-03 |
Precision Biosciences, Inc. |
Co-stimulatory domains for use in genetically-modified cells
|
|
US10662416B2
(en)
|
2016-10-14 |
2020-05-26 |
Precision Biosciences, Inc. |
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
|
|
WO2018073393A2
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
|
|
IL301059B1
(en)
|
2017-04-21 |
2025-12-01 |
Prec Biosciences Inc |
Engineered meganucleases specific for recognition sequences in the pcsk9 gene
|
|
US20200190541A1
(en)
|
2017-04-28 |
2020-06-18 |
Precision Biosciences, Inc. |
Methods for reducing dna-induced cytotoxicity and enhancing gene editing in primary cells
|
|
AU2018266698A1
(en)
|
2017-05-08 |
2019-11-28 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
|
CA3068465A1
(en)
|
2017-06-30 |
2019-01-03 |
Precision Biosciences, Inc. |
Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene
|
|
JP7138702B2
(ja)
|
2017-09-22 |
2022-09-16 |
ベクトン・ディキンソン・アンド・カンパニー |
カテーテルロック溶液としての使用のための４％クエン酸三ナトリウム溶液
|
|
US20200239544A1
(en)
|
2017-10-03 |
2020-07-30 |
Precision Biosciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
|
ES2991988T3
(es)
|
2017-10-30 |
2024-12-05 |
Takeda Pharmaceuticals Co |
Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
|
|
WO2019089913A1
(en)
|
2017-11-01 |
2019-05-09 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
|
ES2955408T3
(es)
|
2018-04-12 |
2023-11-30 |
Prec Biosciences Inc |
Nucleasas modificadas genéticamente optimizadas que tienen especificidad para el gen de la región constante alfa del receptor de linfocitos t humanos
|
|
TW201945388A
(zh)
|
2018-04-12 |
2019-12-01 |
美商精密生物科學公司 |
對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶
|
|
US11369578B2
(en)
|
2018-11-15 |
2022-06-28 |
Bluewillow Biologics, Inc. |
Persistent topical antimicrobial compositions and methods of using the same
|
|
CA3119836A1
(en)
|
2018-11-15 |
2020-05-22 |
Bluewillow Biologics, Inc. |
Nanoemulsion compositions having enhanced permeability
|
|
WO2020132659A1
(en)
|
2018-12-21 |
2020-06-25 |
Precision Biosciences, Inc. |
Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
|
|
CN109845757A
(zh)
*
|
2019-03-15 |
2019-06-07 |
威海市农业科学院 |
果园用病虫害铲除剂及其制备方法、使用方法
|
|
JP7286796B2
(ja)
|
2019-04-03 |
2023-06-05 |
プレシジョン バイオサイエンシズ，インク． |
マイクロｒｎａ適合ｓｈｒｎａ（ｓｈｒｎａｍｉｒ）を含む遺伝子改変免疫細胞
|
|
US20220273715A1
(en)
|
2019-07-25 |
2022-09-01 |
Precision Biosciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
|
JP2022544825A
(ja)
|
2019-08-20 |
2022-10-21 |
プレシジョン バイオサイエンシズ，インク． |
細胞免疫療法のためのリンパ球枯渇投与レジメン
|
|
JP7101375B2
(ja)
*
|
2019-10-17 |
2022-07-15 |
タマ化学工業株式会社 |
除菌組成物及びそれを用いる細菌芽胞の除菌方法
|
|
US20220411479A1
(en)
|
2019-10-30 |
2022-12-29 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
|
WO2021113765A1
(en)
|
2019-12-06 |
2021-06-10 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
|
|
US20230036065A1
(en)
|
2019-12-06 |
2023-02-02 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
|
CN111110631A
(zh)
*
|
2020-03-20 |
2020-05-08 |
苏国霞 |
一种高效广谱的抗菌纳米乳及其制备方法
|
|
WO2021231259A1
(en)
|
2020-05-11 |
2021-11-18 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
|
US20230193230A1
(en)
|
2020-05-12 |
2023-06-22 |
Precision Biosciences, Inc. |
Treatment of retinitis pigmentosa using improved engineered meganucleases
|
|
US20260028412A1
(en)
|
2020-08-10 |
2026-01-29 |
Precision Biosciences, Inc. |
Antibodies and fragments specific for b-cell maturation antigen and uses thereof
|
|
US20240011003A1
(en)
|
2020-08-21 |
2024-01-11 |
Precision Biosciences, Inc. |
Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
|
|
JP2022060747A
(ja)
*
|
2020-10-05 |
2022-04-15 |
サンスター株式会社 |
抗ウイルス用口腔用組成物
|
|
KR20250099412A
(ko)
|
2020-11-12 |
2025-07-01 |
프리시젼 바이오사이언시스 인코포레이티드 |
디스트로핀 유전자 내의 인식 서열에 대해 특이성을 갖는 조작된 메가뉴클레아제
|
|
WO2022150616A1
(en)
|
2021-01-08 |
2022-07-14 |
Precision Biosciences, Inc. |
Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene
|
|
US20250127811A1
(en)
|
2021-01-28 |
2025-04-24 |
Precision Biosciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
|
CA3173051A1
(en)
|
2021-04-22 |
2022-10-22 |
Precision Biosciences, Inc. |
Engineered meganucleases that target human mitochondrial genomes
|
|
KR20240010467A
(ko)
|
2021-04-22 |
2024-01-23 |
프리시젼 바이오사이언시스 인코포레이티드 |
인간 미토콘드리아 게놈을 표적화하는 조작된 메가뉴클레아제
|
|
US20240408235A1
(en)
|
2021-10-19 |
2024-12-12 |
Precision Biosciences, Inc. |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
|
US20250228973A1
(en)
|
2021-10-19 |
2025-07-17 |
Precision Biosciences, Inc. |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
|
WO2023081767A1
(en)
|
2021-11-05 |
2023-05-11 |
Precision Biosciences, Inc. |
Methods for immunotherapy
|
|
IL321936A
(en)
|
2023-01-05 |
2025-09-01 |
Prec Biosciences Inc |
Optimized engineered meganucleases with specificity for the human T-cell receptor alpha constant region gene
|
|
AU2024255934A1
(en)
|
2023-04-14 |
2025-11-20 |
Precision Biosciences, Inc. |
Muscle-specific expression cassettes
|
|
WO2024216116A1
(en)
|
2023-04-14 |
2024-10-17 |
Precision Biosciences, Inc. |
Muscle-specific expression cassettes
|
|
WO2025101946A1
(en)
|
2023-11-08 |
2025-05-15 |
Precision Biosciences, Inc. |
Polypeptide linkers for use in engineered meganucleases
|
|
WO2025233894A1
(en)
|
2024-05-09 |
2025-11-13 |
University Of Miami |
Engineered meganucleases that target human mitochondrial genomes
|